BTS
NVRO

BB&T Securities’s NEVRO CORP. NVRO Stock Holding History

BB&T Securities’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.12M Buy
13,043
+2,170
+20% +$164K 0.01% 757
2019
Q2 		$704K Buy
10,873
+1,693
+18% +$105K 0.01% 956
2019
Q1 		$573K Buy
+9,180
New +$432K 0.01% 1015

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BB&T Securities's NVRO Position: Q3 2019 in Review

BB&T Securities increased its NEVRO CORP. (NVRO) stake by 20% in Q3 2019, buying an estimated $164K and bringing the position to 13,043 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #757.

BB&T Securities first reported a position in NVRO in Q1 2019 and has held it in 3 quarters since. 156 funds tracked by Wall St. Rank hold NVRO as of Q3 2019.

  • BB&T Securities held 13,043 shares of NEVRO CORP. worth $1.12M as of Q3 2019.
  • BB&T Securities bought 2,170 NEVRO CORP. shares in Q3 2019, an estimated $164K.
  • NEVRO CORP. made up 0.01% of BB&T Securities's portfolio in Q3 2019, its #757 holding.
  • BB&T Securities first reported a position in NEVRO CORP. in Q1 2019 and has held it in 3 quarters since.
  • 156 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.